Individuals with known history of glucose 6 phosphate deficiency are excluded from the trial (possible issue with HCQ tolerance)
Phosphate =< 1.1 x ULN
Known selenium deficiency
History of glucose-6-phosphate dehydrogenase deficiency
Patient has Glucose-6-phosphate deficiency
Patients with documented glucose-6-phosphate dehydrogenase deficiency
Must not have known glucose-6-phosphate dehydrogenase (G-6PD) deficiency
History of glucose-6-phosphate dehydrogenase deficiency
Patients must not have known or suspected glucose-6-phosphatase (G-6P) deficiency
Pernicious anemia or other anemias due to vitamin B12 deficiency (due to potential masking of deficiency with leucovorin)
Patients with known glucose-6-phosphate dehydrogenase deficiency
Patients with known glucose-6-phosphate deficiency, psoriasis, porphyria and psychosis
Known glucose-6-phosphate dehydrogenase (G-6PD) deficiency
Known glucose-6-phosphate dehydrogenase (G-6PDH) deficiency
Subjects with known glucose 6 phosphate dehydrogenase deficiency.
History of known Glucose-6-Phosphate Dehydrogenase (G-6-PD) deficiency.
Known glucose-6-phosphate (G-6-P) deficiency
Known or documented bleeding disorders not limited to: anti-phospholipid syndrome, homozygotes for Factor V Leiden deficiency, antithrombin III deficiency, protein C deficiency, protein S deficiency, hyperhomocysteinemia, systemic lupus erythematous, or prothrombin G2020 gene mutation
History of B12 deficiency
